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ABSTRACT
Purpose/Background: Pain can adversely affect muscle functioning by inhibiting muscle contractions. 
Delayed onset muscle soreness was used as a tool to ascertain whether a topical menthol-based analgesic 
or ice was more effective at reducing pain and permitting greater muscular voluntary and evoked force. 
Methods: Sixteen subjects were randomized to receive either a topical gel containing 3.5% menthol or topi-
cal application of ice to the non-dominant elbow flexors two days following the performance of an exercise 
designed to induce muscle soreness. Two days later, DOMS discomfort was treated with a menthol based 
analgesic or ice. Maximum voluntary contractions and evoked tetanic contractions of the non-dominant 
elbow flexors were measured at baseline prior to inducing muscle soreness (T1), two days following induc-
ing DOMS after 20 (T2), 25 (T3) and 35 (T4) minutes of either menthol gel or ice therapy. Pain perception 
using a 10-point visual analog scale was also measured at these four data collection points. Treatment anal-
ysis included a 2 way repeated measures ANOVA (2 × 4). 
Results: Delayed onset muscle soreness decreased (p = 0.04) voluntary force 17.1% at T2 with no treat-
ment effect. Tetanic force was 116.9% higher (p<0.05) with the topical analgesic than ice. Pain perception 
at T2 was significantly (p=0.02) less with the topical analgesic versus ice. 
Conclusions: Compared to ice, the topical menthol-based analgesic decreased perceived discomfort to a 
greater extent and permitted greater tetanic forces to be produced. 
Key Words: analgesia, cryotherapy, delayed onset muscle soreness, menthol, self-reported pain
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INTRODUCTION
Delayed onset muscle soreness (DOMS) is a com-
mon consequence of unaccustomed exercise or 
overtraining especially with the inclusion of exten-
sive eccentric contractions.1 DOMS is commonly 
observed with athletes, weight lifters, and is fre-
quently observed among recreational athletes.1 The 
presence of DOMS inhibits muscle activity or motor 
performance for up to several days following the ini-
tiating event.2 One of the major symptoms of DOMS 
is pain1 which can cause inhibition of force produc-
tion of the involved muscle.1,3
Various methods of ice application including cold 
water immersion have been used to treat DOMS with 
inconclusive results.4 Isabell et al5 found no clini-
cally significant effect of ice massage on DOMS. 
Connolly et al4 countered in their review that cold 
water immersion has been shown to be effective in 
providing some relief of DOMS. Although ice is com-
monly used to alleviate pain6 the evidence for its 
effectiveness for relieving DOMS is contradictory.
Topically applied gels, which contain menthol, are 
also used as analgesics.7-9 Topically applied menthol 
gels result in a cooling sensation and are reported to 
act as a counterirritant to reduce the sensation of 
pain.9 Menthol generates feelings of cold via the tran-
sient receptor potential family of ion channels or 
(TRP’s). TRP’s are found throughout the body, but 
TRPM8 are found mainly within thermosensitive neu-
rons, which in addition to responding to reductions in 
temperature are also particularly sensitive to men-
thol.10-15 TRPM8 serves as a neuronal sensor of cold 
temperatures and is essential for receiving input 
regarding innocuous cool and noxious cold sensa-
tions.16,17 Utilization of calcium imaging techniques 
has demonstrated that upon the application of men-
thol to cloned TRPM8 cells, a heavy intracellular influx 
of calcium ions caused neural depolarization due to 
the opening of non-selective calcium permeable cat-
ion channels.10-15 This increase in sensitization of the 
thermosensitive neurons is what leads to the percep-
tions of coolness with topical menthol application. 
Stimulation of these thermosensitive neurons is also 
associated with an analgesic effect. Afferent thermo-
sensitive neurons which are stimulated by moderate 
cooling or the application of menthol have been found 
to have an  inhibitory effect on the nociceptive afferent 
neurons and on the dorsal-horn neurons which conduct 
pain impulses to the thalamus.18 This analgesic effect of 
menthol was demonstrated in vitro by Haeseler et al19 
when studying the effect of an electrical stimulus 
applied to human skeletal muscle tissue after the tissue 
was exposed to menthol. At various menthol applica-
tion strengths, inactivated sodium channels were mea-
sured to determine the effect on depolarization. It was 
demonstrated that the menthol blocked the alpha sub-
unit of voltage gated sodium channels, therefore caus-
ing hyperpolarization of the nervous membrane and a 
block in the signal of pain transduction. This study dem-
onstrated that the application of menthol could have an 
analgesic effect through exerting an inhibitory gate con-
trol over nociceptive inputs. There are no studies, to 
date, which have compared the analgesic effects of topi-
cal applications of ice with menthol-based gel on DOMS 
symptoms. 
Therefore, the purpose of this study was to compare 
applications of topical menthol with ice on pain, max-
imum voluntary contraction and evoked tetanic force 
during DOMS. It was hypothesized that the menthol 
based topical analgesic would be more effective than 
ice in alleviating DOMS-related symptoms (pain and 
force reductions). Thus menthol’s analgesic effect on 
pain would improve strength output.
METHODS
Participants
Sixteen (Menthol [Biofreeze®] group: 24.2 + 2.1 yrs, 
181.6 + 4.5 cm, 76.1 + 10.3 kg; Ice group: 22.8 + 1.8 
yrs, 178.3 + 3.9 cm, 73.9 + 7.5 kg) healthy, physically 
active subjects (performed regular physical activity a 
minimum of tice per week) including 12 males and 
4 females from Memorial University of Newfoundland 
were randomized to receive either a topical gel con-
taining 3.5% menthol or a topical application of ice 
(using an ice bag) to their non-dominant elbow flexors 
two days following performing an exercise designed to 
induce DOMS in this muscle group. No participant had 
any previous history of cardiopulmonary, neurologi-
cal, cognitive problems, sensory deficits, cold intoler-
ance, or hypersensitivity. The upper limbs were visually 
checked to ensure the absence of any skin wounds, 
lesions and rashes. All subjects were given verbal infor-
mation on the procedure of study as well as a brief 
overview of the purpose of the research. A Physical 
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Activity Readiness Questionnaire (PAR-Q)20 was given 
to every subject to ensure the subjects’ health status 
was sufficient to participate in physical activity. 
Using a random allocation method, subjects were 
divided into two groups; menthol based topical anal-
gesic and ice intervention groups. All subjects read 
and signed a written informed consent document 
before participation that was approved by The Human 
Investigation Committee of Memorial University of 
Newfoundland.
Delayed Onset Muscle Soreness (DOMS) 
Exercise Intervention
Following completion of the informed consent pro-
cess, the PAR-Q and being assigned to an experimen-
tal group all subjects were instructed to sit with their 
upper arm supported on an inclined padded bench 
and hold a free weight dumbbell to provide the resis-
tance in their non-dominant hand. The lower arm 
and dumbbell hung freely over the edge of the bench. 
The one repetition maximum (1 RM) was determined 
for the elbow flexors of non-dominant arm (the left 
arm for all subjects in this experiment)21 using the 
procedure described by Robbins et al.22,23 According 
to this procedure an additional 10% was added to the 
1 RM resistance, in order to successfully induce 
DOMS. Initially, the investigators helped raise the 
resistance to full elbow flexion with minimal assis-
tance from the subject. The subject then performed 
an eccentric contraction to return the weight to start-
ing position2 over a 5s duration. Each subject per-
formed ten sets of 10 repetitions of this eccentric 
exercise of the non-dominant arm. If a subject was 
not able to control the lowering of the weight over 
the 5s duration the resistance was reduced by 2.5 kg 
to ensure the completion of 10 sets. A one-minute 
recovery period was provided between each set. 
DOMS was induced in this study as an experimental 
tool to induce musculotendinous pain.
Menthol Based Topical Analgesic and Ice 
Treatment Interventions
The treatment interventions were applied approxi-
mately 48 hours or two days following the DOMS 
inducing session. For the menthol gel group, 2ml of 
Biofreeze®, a gel containing 3.5% menthol was applied 
topically over the belly of the biceps brachii. The mode 
of application did not involve substantial f orce, 
 pressure or rubbing and thus any reflex activation 
would not have been expected. This dose of Biofreeze®, 
was based upon the estimate that the average skin sur-
face area over the biceps brachii was approximately 
400 cm² and the recommended dosage of Biofreeze® 
of 1 ml per 200 cm².24 Twenty minutes (T2) following 
the application of the menthol gel each participant 
completed an assessment of their MVC, evoked tetanic 
force and perceptions of pain. These assessments 
were repeated at 25 (T3) and 35 (T4) minutes follow-
ing the application of the menthol gel. Whereas the 
effect of menthol-induced reduced vascular conduc-
tance has been reported to endure for at least 20
min,24,25 the subjective cooling effect has been reported 
to last up to 70 min in some subjects (mean 32 min).9
The protocol for application of the ice was similar to 
that of the menthol gel. Subjects who were random-
ized into this group underwent the same baseline 
assessment of their MVC evoked tetanic force and 
their perceptions of pain (T1) prior to inducement 
of DOMS. Then these individuals reported to the 
laboratory approximately 48 hours (or 2 days) fol-
lowing the DOMs inducement protocol. At this time 
.5kg of crushed ice in a plastic bag was placed over 
the non-dominant biceps brachii for 20 minutes and 
then removed.26,27 Assessments of MVC, evoked tetanic 
force and their perceptions of pain were repeated 
immediately following the removal of the ice (T2), 
and at 25 (T3) and 35 (T4) minutes following initial 
application of the ice.
One researcher performed all the intervention appli-
cations, while another researcher was blinded to the 
group allocation during testing. Anonymous codes 
were assigned for analysis so that only the third 
researcher who did not perform the data analysis 
was cognizant of group allocation.
Dependent Variables
Measurements of voluntary (elbow flexor isometric 
MVC) and evoked (tetanic force) contractile properties 
were randomly allocated. While subjects sat upright in 
a chair, the left shoulder and elbow were flexed at 90° 
with the forearm vertical and fully supinated. The 
upper arm was fastened to the chair via an adjustable 
strap to avoid movement during  voluntary force 
 measurements. Both forearm and wrist of the testing 
arm were rested on a padded support and secured to a 
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strap attached to a high tension wire to a Wheatstone 
bridge configuration strain gauge (Omega Engineering 
Inc., LCCA 250, Don Mills, Ontario, Canada), amplified 
(Biopac Systems Inc., Holliston, Massachusetts; DA 
100 and analog to digital converter MP100WSW) and 
monitored on computer (Dell Inspiron 6000, St. John’s, 
Newfoundland, Canada). All data were stored on a 
computer at a sampling rate of 2000 Hz. Data were 
recorded and analyzed with a commercially designed 
software program (AcqKnowledge III, Biopac Systems 
Inc., Holliston, Massachusetts).
To assess peripheral (muscle) force changes associ-
ated with DOMS and the treatment interventions, 
bipolar surface stimulating electrodes were secured 
to the proximal anterior portion of the forearm flexors 
and deltoid-biceps brachii intersection. Similar to 
previous research from this laboratory30 stimulating 
electrodes, 4–5 cm in width were constructed in the 
laboratory from aluminum foil, paper coated with 
conduction gel (Signa Creme, Parker Laboratories, 
Fairfield, New Jersey) and immersed in water. The 
electrodes length was sufficient to wrap the width 
of the muscle belly. The electrodes were placed in 
approximately the same position for each subject. 
Tetanic stimulation was evoked with electrodes con-
nected to a high-voltage stimulator (Digitimer Stimu-
lator Model DS7H+ Hertfordshire, UK). A stimulation 
frequency of 50 Hz was maintained for a duration of 
3 s with a pulse duration set at 50 μs. Stimulation was 
started with voltage at 100 V and amperage at 200 mA 
and progressively increased by 200 mA until 1 ampere 
was reached. If the subject could tolerate greater force 
then voltage was increased incrementally by 50 V. 
The purpose of the tetanic stimulation was to deter-
mine the maximum evoked force output that could 
be tolerated (pain perception) by the individuals. 
Maximum Voluntary Contraction (MVC) Force
All subjects performed 2–3 MVCs trials. Verbal instruc-
tions were given to each subject to maximally con-
tract the elbow flexors as hard and fast as possible. 
During the contraction, verbal motivation and visual 
feedback was provided by the investigator to promote 
a maximal response. The isometric contraction lasted 
for 4-5 s. Subjects were given a rest period of at least 2 
min between each MVC. Peak force was measured as 
the greatest difference between the pre-MVC or rest-
ing value (approximately 1s prior to  contraction) and 
the greatest force amplitude. If there was a >5% dif-
ference between the first 2 MVC trials, the subject 
was asked to perform a third trial, and the highest 
MVC force was recorded.
Visual Analogue Scale
A soreness rating scale was used with a visual ana-
logue scale (VAS) to collect the soreness perception 
levels prior to testing.2,28 Since the subject’s were 
maximally exerting and physically restricted during 
the MVCs and with the treatment applications, sub-
jects were instructed to verbally report the percep-
tion of soreness levels to the researchers who would 
record the response on the 10-point, 100 mm VAS 
scale. VAS has been reported to be a valid indicator 
of pain with excellent consistency.29
Statistical Analysis 
Treatment analysis included a 2 way repeated mea-
sures ANOVA (2 × 4)(GB-STAT for MS Windows, ver-
sion 7.0, Dynamic Microsystems Inc., Silver Spring, 
MD) with factors including treatment intervention 
(menthol based topical analgesic and ice) and time 
(T1-T4). The effect of DOMS on voluntary and evoked 
forces was analyzed with repeated measures ANOVA. 
Differences were considered significant when p val-
ues were below an alpha level of 0.05. A post hoc 
Bonferroni- Dunn’s procedure was used to detect 
specific significant differences. Effect sizes (ES = 
mean change / standard deviation of the sample 
scores) and confidence intervals were also calculated 
and reported.31 Cohen applied qualitative descriptors 
for the effect sizes with ratios of <0.41, 0.41-0.7, and 
>0.7 indicating small, moderate and large changes 
respectively. Data were reported as mean + SD. 
RESULTS 
A post-hoc analysis of the statistical power (for a 
two-sided test) calculated for an alpha of 0.05 ranged 
from 0.2 for MVC force measures (insignificant find-
ings) to 0.84, 0.97 and 0.98 for tetanic force, VAS 
scores at rest and VAS scores during the MVC respec-
tively. There were no significant differences between 
groups for any baseline (T1) measures. 
Voluntary Muscle Force and Activation
There was no significant main effect or interactions 
for the treatment interventions. There was a  significant 
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(p = 0.04; ES=0.54) main effect for time, with a 
DOMS-induced decrease in MVC force of 17.1% from 
T1 to T2 (Figure 1). There were no significant MVC 
force differences between T2, T3 and T4 (Table 1). 
Evoked Muscle Force
There was a tendency with a large effect size (p = 
0.06; ES=1.2) for tetanic force to decrease over time 
with 43.4%, 35.1%, and 31.2% decreases of T2, T3 and 
T4 respectively, compared to T1 (Figure 2). Tetanic 
force changes illustrated a significant main effect for 
the treatments (p<0.05; ES=1.1) with the menthol 
based topical analgesic allowing 116.9% greater tetanic 
force (89.4 N ± 60.7) output than the ice treatment 
(41.2 ± 43.6). Although not statistically significantly 
different (p=0.17), tetanic forces following the ice 
treatment at T2, T3 and T4 were 56.5%, 78.7% and 
66.1% lower than tetanic forces following the respec-
tive times with the Biofreeze treatment (Table 1).
Pain Scales
There was no significant difference in pain percep-
tion pre-treatment. Although there was no significant 
Figure 1: Figure illustrates a main effect for time associated 
with changes in maximum voluntary contraction (MVC) force 
of the non-dominant elbow ﬂ exors. The asterisk indicates a 
signiﬁ cant (p=0.04) difference between T1 (pre-test) and T2 
(2 days following DOMS and 20 min following intervention 
application) MVC force. Columns and bars represent means ± 
standard deviation (SD).
Figure 2: Figure illustrates a tendency (p=0.06) with a large 
effect size (ES=1.2) for a main effect for time (data collapsed 
over treatments) associated with evoked tetanic force of the 
non-dominant (DOMS-induced) elbow ﬂ exors. Columns and 
bars represent means ± standard deviation (SD).
Table 1. Treatment by time interactions. The ﬁ rst series of numbers represents mean ± standard 
deviations whereas the subsequent numbers below represent the 95% conﬁ dence interval (CI).
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group by time interaction, soreness perception asso-
ciated with the MVC showed trends with large effect 
size for both treatment and time. The soreness associ-
ated with a MVC following ice application (3.9 ± 0.5) 
tended to be 33% greater (p=0.08; ES=1.8) than fol-
lowing the topical analgesic application (3.0 ± 0.4). 
Soreness associated with a MVC had a tendency with 
a small effect size (p=0.1; ES=0.12) to decline over 
time with 13.1% and 17.7% less soreness respectively, 
perceived at T3 (3.3 ± 0.98) and T4 (3.1 ± 1.2) com-
pared to T1 (3.8 ± 1.02). There was a significant 
(p=0.025; ES=1.2) difference in soreness perception 
with the VAS scale between the application of ice and 
the menthol based topical analgesic. Soreness percep-
tion was 63.1% less with application of the topical 
analgesic (1.1 ± 0.4) compared to the ice (3.1 ± 1.7). 
DISCUSSION
The most important results of this study suggest that 
a menthol based topical analgesic was more effec-
tive than ice for relieving soreness associated with 
DOMS while at rest or during muscle contractions. 
The topical analgesic also permitted greater evoked 
tetanic forces to be produced as compared to ice.
Menthol and ice are widely used as topical analge-
sics. Ice is reported to be effective in reducing pain 
with soft tissue injuries32,33 and has also been widely 
used in relieving the symptoms of DOMS.4,34 It is sug-
gested that the cold temperature significantly reduces 
the pain perceived due to DOMS.34 However, other 
studies report that ice massage5,35 have minimal 
effects on reducing DOMS symptoms. Although ice 
is commonly used to alleviate pain,6 there is conflict-
ing evidence regarding its effectiveness for relieving 
DOMS. In the present study ice was less effective 
than a menthol based topical analgesic for relieving 
DOMS symptoms. The menthol based topical analge-
sic showed both large magnitudes of change over the 
testing periods as well as achieving minimal clinical 
importance. A number of studies36-38 have indicated 
that a change of 10-13 mm on a VAS scale of 100 mm 
represents the minimal clinically significant differ-
ence. The present study anchored numbers from 0-
10 with a distance of 10 mm between each numeral. 
The VAS score with the menthol based topical anal-
gesic of 1.1 was substantially lower than the score 
associated with the ice treatment (3.1) illustrating a 
clinically significant difference in pain perception.
Menthol has been reported to be effective in reliev-
ing pain with mild to moderate muscle strains.39 Top-
ical application of a menthol gel along with the 
chiropractic adjustment showed significant reduc-
tion in low back pain.40 Yosipovitch et al.9 reported 
that while menthol has a high skin irritating effect it 
did not differ from alcohol in reducing itch and pain 
sensations. However, Galeotti et al.7 indicated that 
menthol’s analgesic properties are mediated through 
a selective activation of opioid receptors. The feeling 
of coolness experienced when applying menthol is 
achieved by sensitization of the thermosensitive 
neurons that also possess analgesic properties.7 Using 
mice, Galeotti et al.7 reported an increase in heat 
pain threshold. Furthermore, menthol has been 
shown to activate temperature-activated transient 
receptor potential (TRP) ion channels such as 
TRPM8,41 TRPV3 and inhibits TRPA1 providing a 
rationale for its use as an analgesic.8 Stimulation of 
these thermosensitive neurons is also associated 
with an analgesic effect. Afferent thermosensitive 
neurons are stimulated by the application of men-
thol, have an inhibitory effect on the nociceptive 
afferent neurons and dorsal-horn neurons, which 
conduct pain impulses to the thalamus.18 
Another possible mechanism for the analgesic effect 
of menthol may be related to the inflammation or 
swelling associated with DOMS.4 Olive et al.24 reported 
a significant reduction in vascular conductance 
within 60s of menthol application, which was main-
tained for at least 10 minutes. Similarly animal stud-
ies have shown a reduced pressor response to exercise 
(decreased blood pressure) reducing blood flow to 
the application area.42,43 Unfortunately the extent of 
swelling was not measured in the present study and 
thus the effect of the menthol gel on DOMS-induced 
inflammation cannot be verified or quantified in this 
study. Hence, the mechanisms underlying the lower 
soreness scores on the VAS cannot be specified in the 
present study but may be attributed to one or a com-
bination of inflammation reduction, counterirritant 
activation and inhibition of specific thermosensitive 
ion channels, or opioid receptors.
The menthol based topical analgesic permitted greater 
evoked tetanic forces following DOMS than ice. Unfor-
tunately, VAS for pain was not employed during the 
tetanic contractions. However, all  participants in this 
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study and the many previous studies from this labora-
tory have all commented on the substantially greater 
discomfort experienced during evoked tetanic versus 
voluntary contractions. Electrical stimulation of mus-
cle through the skin can activate cutaneous pain 
receptors,44 with greater magnitudes of pain experi-
enced with increasing frequency of stimulation.45 
Furthermore the stimulator provides synchronous 
muscle activation45 rather than a typical physiological 
asynchronous stimulation46 resulting in a cramp-like 
sensation. This cramp-like contraction can also stim-
ulate mechanical nociceptors contributing to the pain 
sensation.44 Hence in the present study, the milder 
discomfort associated with a voluntary contraction 
did not allow subjects to differentiate between the 
topical analgesic and ice but the greater discomfort or 
pain of the tetanic cramp-like contraction was amelio-
rated to a greater degree by the menthol based topical 
analgesic. Thus the menthol based topical analgesic 
provided greater pain tolerance allowing higher evoked 
contraction forces to be produced. In terms of injury 
rehabilitation, the menthol-based analgesic would allow 
higher contraction forces to be elicited with functional 
electrical stimulation training. 
The greatest limitation of the present study is related 
to the individual responses to pain. Behm and St-
Pierre47 reported a correlation 0.1 between pain and 
muscle activation. The high variability with some of 
the data in the present study also reflects the very dif-
ferent responses of each individual to pain. Thus, pre-
dictably there was no significant correlation between 
pain and changes in force. A further limitation could 
have been that the treatments could have distinctive 
time courses. The present study utilized early and 
delayed testing times for the treatments in order to 
identify if one treatment was more likely to have a 
greater effect soon after or later after application.
CONCLUSIONS
The results of the present study indicate that a menthol 
based topical analgesic was more effective than ice for 
decreasing DOMS-induced symptoms of pain and 
increasing evoked tetanic force. Hence, a menthol 
based analgesic would be recommended for reducing 
DOMS-induced symptoms for at least 35 minutes after 
the application. While patients with injuries were not 
employed in this study, the greater tetanic force with 
the menthol analgesic might  suggest that more intense 
or aggressive muscle stimulation therapy during reha-
bilitation might be possible with such a therapeutic 
agent. Finally DOMS was used as a model to induce 
pain in the present study. The results may also apply to 
other musculoskeletal pain afflictions; however further 
research should investigate injured populations (e.g. 
strains, sprains). Furthermore, previous research24 indi-
cates that the effects of menthol-based gels may work 
within a minute of application making them more time 
efficient than ice.
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